Skip to search formSkip to main contentSkip to account menu

Monoclonal Antibody Therapy

Known as: antibody therapy, monoclonal, monoclonal antibody therapies, MoAb 
The use of monoclonal antibodies in the treatment of any disease or disorder.
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Immunotherapy
Monoclonal Antibodiesantibody therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
The field of Alzheimer’s disease (AD) research has grown exponentially over the past few decades, especially since the isolation… 
Review
2017
Review
2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and…
Review
2014
Review
2014
Fc receptor-dependent mechanisms of monoclonal antibody therapy of cancer.
Targeted therapies like treatment with monoclonal antibodies (mAbs) have entered the arsenal of modern anticancer drugs. mAbs… 
Highly Cited
2011
Highly Cited
2011
MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy.
Epidermal growth factor receptor (EGFR) monoclonal antibodies (mAb) are used widely to treat metastatic colorectal cancer (mCRC… 
Highly Cited
2011
Highly Cited
2011
Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy
Tumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates and are difficult to study… 
Highly Cited
2010
Highly Cited
2010
Interference of monoclonal antibody therapies with serum protein electrophoresis tests.
To the Editor: During routine serum protein electrophoresis (SPE), we recently detected an apparent IgG heavy-chain… 
2009
2009
Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis
Interleukin-6 is a multifunctional cytokine that is critical for T/B-cell differentiation and maturation, immunoglobulin… 
Review
2006
Review
2006
Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Background:Monoclonal antibodies constitute a relatively new class of therapeutic agent designed to interact with specific target… 
Review
2003
Review
2003
Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.
Interleukin (IL)-6, a pleiotropic cytokine with varied systemic functions, plays a major role in inflammatory processes. It… 
Highly Cited
1992
Highly Cited
1992
Humanised monoclonal antibody therapy for rheumatoid arthritis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)